115250-32-3

Upstream product

• 115250-30-1 ((3S,4S,5R,6R)-3,4,5,7-Tetrakis-benzyloxy-2,6-dihydroxy-heptyl)-phosphonic acid dimethyl ester 
• 13096-62-3 (3R,4S,5R,6R)-3,4,5-tris(benzyloxy)-6-((benzyloxy)methyl)tetrahydro-2H-pyran-2-one 
• 140926-87-0 3,4,5,7-Tetra-O-benzyl-1-deoxy-1-(dimethoxyphosphoryl)-α-D-gluco-2-heptulopyranose 
• 4291-69-4 2,3,4,6-Tetra-O-benzyl-D-glucopyranose 

Downstream Products

• 110391-10-1 (4R,5S,6R)-4,5,6-tris(benzyloxy)-3-((benzyloxy)methyl)-2-cyclohexen-1-one 
• 114779-32-7 1D-(1,3,6/2)-6-amino-4-benzyloxymethyl-1,2,3-tri-O-benzyltrihydroxycyclohex-4-ene 
• 106054-18-6 validoxylamine G 
• 99695-34-8 (1R,2S,3S,4R)-2,3,4-tri-O-benzyl-5-(benzyloxymethyl)-cyclohex-5-ene-1,2,3,4-tetrol 
• 140926-88-1 tetra-O-benzyl-N-phthaloylvalienamine 
• 1413373-68-8 C₅₆H₅₈F₂N₂O₆ 
• 1413373-66-6 C₅₆H₅₈N₂O₇ 
• 1413373-64-4 C₅₆H₆₀N₂O₇ 
• 1413373-62-2 C₅₆H₅₈N₂O₆ 
• 1413373-60-0 C₅₃H₅₂N₂O₆ 
• 1413373-54-2 C₁₃H₁₆F₂O₆ 
• 1413373-52-0 C₄₈H₄₆F₂O₆ 
• 1413373-50-8 C₄₈H₄₆O₇ 
• 1413373-48-4 C₄₈H₄₈O₇ 

Relevant academic research and scientific papers

FAMILY OF ARYL, HETEROARYL, O-ARYL AND O-HETEROARYL CARBASUGARS

The present invention relates to a compound of the following formula (I): as well as its process of preparation, pharmaceutical and cosmetics composition comprising it and use thereof, notably as an inhibitor of the sodium-dependent glucose co-transporter, such as SGLTl, SGLT2 and SGLT3, in particular in the treatment or prevention of diabetes, and more particularly type-II diabetes, diabetes-related complications, such as arthritis of the lower extremities, cardiac infarction, renal insufficiency, neuropathy or blindness, hyperglycemia, hyperinsulinemia, obesity, hypertriglyceridemia, X syndrome and arteriosclerosis, as well as for its use as an anticancer, anti-infective, anti-viral, anti-thrombotic or anti- inflammatory drug, or for lightening, bleaching, depigmenting the skin, removing blemishes from the skin, particularly age spots and freckles, or preventing pigmentation of the skin.